Xiaoyang Ren

2.2k total citations · 1 hit paper
39 papers, 1.5k citations indexed

About

Xiaoyang Ren is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoyang Ren has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoyang Ren's work include interferon and immune responses (4 papers), Cell death mechanisms and regulation (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Xiaoyang Ren is often cited by papers focused on interferon and immune responses (4 papers), Cell death mechanisms and regulation (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Xiaoyang Ren collaborates with scholars based in China, United States and New Zealand. Xiaoyang Ren's co-authors include Xiangwei Wu, Yahong Lin, Yibin Deng, Lin Yang, Dmitri O. Lapotko, Ekaterina Y. Lukianova‐Hleb, Rupa R. Sawant, Vladimir P. Torchilin, Wenzhi Wang and Xin Zhao and has published in prestigious journals such as Nature, Cell and Advanced Materials.

In The Last Decade

Xiaoyang Ren

36 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-strength hydrogels: Fabrication, reinforcement mechanisms, and applications

2023 170 citations Xiaoyang Ren et al. profile →

Peers

Countries citing papers authored by Xiaoyang Ren

Since Specialization

Citations

This map shows the geographic impact of Xiaoyang Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Ren more than expected).

Fields of papers citing papers by Xiaoyang Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyang Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Ren. The network helps show where Xiaoyang Ren may publish in the future.

Co-authorship network of co-authors of Xiaoyang Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Ren. A scholar is included among the top collaborators of Xiaoyang Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Ren. Xiaoyang Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhanced Tri‐Atom Ru‐Based Catalyst for Hydrogen Evolution Reaction via Rapid Pyrolysis of Precursor 2025 ·Advanced Functional Materials ·Xiaoyang Ren, Mengjiao Li, Kaiyue Wang, Ruihu Lu, (unknown), Panpan Li, Yi Yao, (unknown), Ziyun Wang, (unknown)	8
2	Modeled Single‐Atomic‐Site Pt Catalyst with Well‐Defined Coordination Structure for Hydrosilylation Reaction 2025 ·Angewandte Chemie International Edition ·(unknown), (unknown), (unknown), Kaiyue Wang, Xiaoyang Ren, Ruhao Wang, Kai Sun, Zheng Chen, (unknown), Shubo Tian	1
3	Identifying the critical oncogenic mechanism of LDHA based on a prognostic model of T-cell synthetic drivers 2023 ·International Immunopharmacology ·Guanghui Wang, (unknown), (unknown), Yadong Wang, Kai Wang, Xiaoyang Ren, Jiajun Du	3
4	IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC 2023 ·Clinical Cancer Research ·Sonia Patel, Monique B. Nilsson, Yan Yang, Xiuning Le, Hai T. Tran, Yasir Y. Elamin, Xiaoxing Yu, Fahao Zhang, Alissa Poteete, Xiaoyang Ren, Li Shen, Jing Wang, Seyed Javad Moghaddam, Tina Cascone, Michael A. Curran, Don L. Gibbons, John V. Heymach	62
5	Cezanne promoted autophagy through PIK3C3 stabilization and PIK3C2A transcription in lung adenocarcinoma 2023 ·Cell Death Discovery ·(unknown), Jiahao Li, (unknown), Kai Wang, Xiaoyang Ren, (unknown), Jiajun Du	3
6	A Spectral–Spatial Method for Mapping Fire Severity Using Morphological Attribute Profiles 2023 ·Remote Sensing ·Xiaoyang Ren, (unknown), Yi Wang	3
7	A Deep Neural Network with Residual Skip Connections for Channel Estimation 2022 ·Xiaoyang Ren, (unknown), Zhiyong Liu	1
8	The Application of Mobile Telehealth System to Facilitate Patient Information Presentation and Case Discussion 2020 ·Telemedicine Journal and e-Health ·Xiaoyang Ren, Yunkai Zhai, Xiaoqin Song, (unknown), Dongwei Dou, Yuhong Li	17
9	CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis 2020 ·Cancer Cell International ·Dongwei Dou, Xiaoyang Ren, Mingli Han, Xiaodong Xu, Xin Ge, Yuanting Gu, Xinxing Wang, Song Zhao	79
10	Design and Implementation of a Message-Based Regional Telemedicine System to Achieve High Availability and Scalability 2018 ·Telemedicine Journal and e-Health ·Xiaoyang Ren, (unknown), (unknown), (unknown), (unknown), Mingxia Chen, Yunkai Zhai, (unknown), (unknown)	10
11	Video-assisted thoracoscopic left lower lobectomy with pulmonary cryptococcosis performed by a two-port approach method 2016 ·ASVIDE ·Yandong Zhao, Wenjie Jiao, Tong Qiu, Yunpeng Xuan, Xiaoyang Ren	0
12	Left lower lobe sleeve lobectomy for lung cancer using the Da Vinci surgical system 2016 ·Journal of Cardiothoracic Surgery ·Yandong Zhao, Wenjie Jiao, Xiaoyang Ren, (unknown), Tong Qiu, Bo Fu, (unknown)	13
13	Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis 2015 ·Genetics and Molecular Research ·Yan Zhao, Hairong He, (unknown), Xiaoyang Ren, (unknown), Yiping Dong, (unknown)	5
14	Effects of CYP3A4 polymorphisms on the plasma concentration of voriconazole 2014 ·European Journal of Clinical Microbiology & Infectious Diseases ·Hairong He, (unknown), Xiaoyang Ren, (unknown), Yajing Zhai, (unknown), Yalin Dong, (unknown)	32
15	Plasmonic Nanobubbles Rapidly Detect and Destroy Drug-Resistant Tumors 2012 ·Theranostics ·Ekaterina Y. Lukianova‐Hleb, Xiaoyang Ren, (unknown), Xiangwei Wu, Michael E. Kupferman, Dmitri O. Lapotko	25
16	Plasmonic Nanobubbles Enhance Efficacy and Selectivity of Chemotherapy Against Drug‐Resistant Cancer Cells 2012 ·Advanced Materials ·Ekaterina Y. Lukianova‐Hleb, Xiaoyang Ren, Joseph A. Zasadzinski, Xiangwei Wu, Dmitri O. Lapotko	93
17	Lung-Cancer Chemoprevention by Induction of Synthetic Lethality in Mutant KRAS Premalignant Cells In Vitro and In Vivo 2011 ·Cancer Prevention Research ·Shao‐Yi Huang, Xiaoyang Ren, Lai Wang, Ling Zhang, Xiangwei Wu	21
18	Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis 2010 ·Nature ·Ling Zhang, Xiaoyang Ren, Eckhard Alt, Xiaowen Bai, Shao‐Yi Huang, (unknown), Patrick M. Lynch, Mary Pat Moyer, (unknown), Xiangwei Wu	115
19	Bypass NF-κB-mediated survival pathways by TRAIL and Smac 2007 ·Cancer Biology & Therapy ·Xiaoyang Ren, (unknown), Jeffery N. Myers, Xiangwei Wu	13
20	A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis 2003 ·Cell ·Yibin Deng, Xiaoyang Ren, Lin Yang, Yahong Lin, Xiangwei Wu	477

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact